Jamais vu makes familiar places, faces, and words suddenly feel strange. Explore the science behind this eerie phenomenon and ...

The trial met the primary and secondary endpoints with statistically significant placebo-adjusted improvements at Week 3 in the YMRS total score ...

A Japanese case report describes a woman with drug-resistant epilepsy whose seizures fell by about 60 percent after deep brain stimulation of only one side of the thalamus.

Epilepsy is a neurological condition characterised by a tendency to experience recurrent, unprovoked seizures. A seizure ...

On Tuesday, Rapport Therapeutics Inc. ( RAPP) announced positive topline results from its Phase 2 trial of RAP-219 in adults with acute bipolar mania, meeting the primary and secondary endpoints and ...

An estimated one third of older people with dementia in England remain undiagnosed. Rachel Daly, admiral nurse at Dementia UK ...

Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) will present new data at IDWeek 2026 that reinforce the role of Fetroja ® ...

Millions of Americans struggle with sleep. Many believe cannabis or CBD helps, but clinical evidence remains unconvincing. Neither is FDA-approved for treating insomnia.

Diagnostic delays in narcolepsy and idiopathic hypersomnia (IH) persist largely because of low awareness among patients, ...

The Glore Psychiatric Museum in St. Joseph, Missouri, attracts lovers of the macabre, odd and supernatural for its eerie ...

Rising fuel costs, discontent with the state of schools, declining public services and a housing crisis have created perfectly stormy weather for an autumn of protests in Europe.